Cue Biopharma, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the certified results of the 2026 Annual Meeting of Stockholders held on April 13, 2026. The filing covers corporate governance matters, including the election of directors, ratification of auditors, executive compensation advisory votes, and a proposed reverse stock split.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on voting outcomes and corporate actions.
Material Changes and Corporate Actions
- Board of Directors Election: Stockholders elected six nominees to the Board. Notably, Usman Azam resigned as President, CEO, and Board member effective March 26, 2026; all votes cast for Dr. Azam were disregarded.
- Reverse Stock Split Approval: Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-30 and 1-for-50. The Board retains sole discretion to determine the exact ratio and timing without further shareholder approval.
- Auditor Ratification: RSM US LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Executive Compensation: A non-binding advisory proposal on executive compensation was approved.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or specific risk factors beyond the standard implications of a reverse stock split and leadership transition. The implementation of the reverse stock split remains subject to Board discretion regarding the specific ratio and timing.
Investor Verification Checklist
- Verify the exact reverse stock split ratio and implementation date once announced by the Board.
- Confirm the appointment of a permanent CEO following the resignation of Usman Azam and the interim leadership of Lucinda Warren.
- Review the full proxy statement filed on March 16, 2026, for detailed biographies of the newly elected directors.
- Monitor Nasdaq Capital Market compliance status regarding the reverse stock split.